Traders should confirm that any legacy positions in CELG-RI (Celgene CVRs) or related preferred shares have been settled; no further SEC reporting will occur for these instruments. The move is administrative and confirms the final wind-down of post-acquisition obligations.
Price Chart
Executive Summary
Bristol-Myers Squibb Company is terminating registration for certain securities under Section 12(g) of the Exchange Act, reporting zero holders of record for the affected classes. This deregistration follows the completion of its acquisition of Celgene, under which the Celgene Contingent Value Rights and related securities were extinguished or settled.
Key Facts
- Bristol-Myers Squibb is filing Form 15-12G to terminate registration of several securities, including Celgene Contingent Value Rights and $2 Convertible Preferred Stock.
- Approximate number of holders of record for the affected securities is zero, indicating these instruments have been fully settled or retired.
- The filing references Rule 12g-4(a)(1) and Rule 15d-6, which allow deregistration when a class of securities has fewer than 300 holders or is no longer publicly traded.
- This action follows the 2019 acquisition of Celgene, after which the contingent value rights (CVRs) were triggered and subsequently expired or were redeemed.
Financial Impact
No ongoing financial impact — the securities being deregistered (including CVRs and preferred stock) are legacy instruments from the Celgene acquisition that have been fully resolved.
Risk Factors
- Minimal risk for current investors — this is a procedural filing reflecting a completed transaction.
- Potential confusion for retail investors holding outdated positions or unaware that CVRs have expired.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001140361-26-011729 |
| Document: 0001140361-26-011729-index-headers.html | 0001140361-26-011729 |
| Document: 0001140361-26-011729-index.html | 0001140361-26-011729 |
| Document: 0001140361-26-011729.txt | 0001140361-26-011729 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 17, 2026 27w ago | DEFA14A | — | awaiting T+20 | — | — |
Mar 27, 2026 30w ago | 15-12G | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers